Connect with us
European Gaming Congress 2024

Artificial Intelligence

Unlocking the Future of Drug Discovery with Artificial Intelligence

Published

on

unlocking-the-future-of-drug-discovery-with-artificial-intelligence

BCC’s newly released report, titled “Global Artificial Intelligence in Drug Discovery Market,” unveils the extraordinary impact of artificial intelligence (AI) on the pharmaceutical and biotech sectors. Authored by Ms. Surbhi Jagtap, Senior Analyst, this study provides invaluable insights into the AI-driven revolution in drug discovery.
BOSTON, Sept. 22, 2023 /PRNewswire/ — The report highlights a groundbreaking discovery: Over 150 small-molecule medications are currently under development by biotech companies utilizing an AI-first strategy. Astonishingly, more than 15 of these drugs are already in clinical trials, demonstrating the remarkable power of AI in driving innovation. This AI-powered pipeline is experiencing rapid growth, expanding at approximately 40% each year.

Stand Out Facts
AI and machine learning have become integral components of the drug discovery processes in the pharmaceutical and biotech industries. AI technology has accelerated the early stages of drug research, enabling the analysis of vast datasets, identification of prospective therapeutic candidates, and optimization of molecular structures.Pharmaceutical companies are forging alliances and partnerships with AI-focused startups, leveraging cutting-edge AI tools, algorithms, and knowledge. AI’s potential to predict medication behavior in the body, eliminate unnecessary molecules before leaving the computer, and reduce lab labor time is revolutionizing drug discovery, making it faster and more cost-effective. By forecasting effective drug candidates, AI significantly reduces the need for laboratory experiments.Now is the Time to Act
The AI in the Drug Discovery sector is witnessing unprecedented growth, underscored by a significant increase in venture capital funding for AI-driven biotech startups, reaching approximately $1.9 billion in 2020 alone. Although this data is from 2020, it is a testament to the sector’s robust expansion. In 2022, the AI startup investment landscape continued to thrive, with 27 deals totaling about $1.94 billion (€1.8 billion) involving pharmaceutical and biotech entities. This growth is further fueled by burgeoning research collaborations between top pharmaceutical companies and AI-focused biotech and technology vendors, coupled with a steady stream of new product releases, scientific discoveries, and proof-of-concept studies.
Venture capital firms, pharmaceutical giants, and technology leaders are making substantial investments in AI for drug discovery, fueling in-depth research and advancements in the field. Collaborations with contract research organizations (CROs), known for their adaptability and specialization, are proving to be an effective strategy for harnessing AI solutions in drug discovery. For example, Pfizer is utilizing the supercomputer IBM Watson and machine learning and deep learning technologies to develop innovative immuno-oncology medications. Sanofi and Exscientia have also joined forces to explore treatments for metabolic disorders using advanced AI technology.
Learn More Today
The global market for AI in drug discovery is estimated at $1.2 million in 2022 and is expected to grow at a CAGR of 29.6% to nearly $5.7 billion by 2028. The information in this report is a must-read for a number of professionals in the AI and pharmaceutical sectors.
To learn more or make a purchase, visit BCC Research.
Download Report Overview
About BCC Research
BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts’ goal is to help you make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ:BCC Research LLC49 Walnut Park, Building 2Wellesley, MA 02481, [email protected]+1 781-489-7301
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email [email protected] or visit www.bccresearch.com/media to request access to our library of market research.
Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/unlocking-the-future-of-drug-discovery-with-artificial-intelligence-301934565.html

Continue Reading
Advertisement

Artificial Intelligence

NTT DATA signs agreement to acquire Aoop and will become a leader in ServiceNow solutions in Latin America

Published

on

ntt-data-signs-agreement-to-acquire-aoop-and-will-become-a-leader-in-servicenow-solutions-in-latin-america

BIELEFELD, Germany and SÃO PAULO, Oct. 11, 2024 /PRNewswire/ — NTT DATA Business Solutions AG, a global unit of NTT DATA, announces that the agreement for the acquisition of Aoop, a leading ServiceNow implementation company in Brazil, has been signed. The terms of the acquisition have been finalized between the companies and will be completed following approval from the Administrative Council for Economic Defense (CADE). Founded in 2017, Aoop supports customers across various industries and is a specialist in the acceleration of automated digital strategies. With Aoop, NTT DATA will expand its operations in the Latin American ServiceNow solutions market, complementing a recent acquisition in the UK focused on strengthening this offering in Europe and the United States.

“With the acquisition of Aoop, we significantly increase our competitive strength in Brazil by offering both SAP and ServiceNow solutions, positioning us alongside market leaders,” says Norbert Rotter, CEO, NTT DATA Business Solutions. “This move will not only secure us a leading position in the fast-growing ServiceNow ecosystem but will also integrates a company with a strong market presence and solid financials to NTT DATA. It will be a significant step in driving our strategic objectives, strengthening our partnership with ServiceNow and our commitment to establishing a Center of Excellence in the region.”
Ricardo Fachin, Managing Director of NTT DATA Business Solutions Brazil adds: “The acquisition of Aoop will solidify our leading position in the Brazilian market. It will enhance synergies with our other Latin American and U.S. operations, accelerating our regional growth. As part of ServiceNow’s global strategy, Brazil will become a significant shoring center for the group. Aoop’s comprehensive portfolio, covering all ServiceNow verticals, will benefit all NTT DATA customers.”
With a strategy focused on driving the future of organizations and providing full lifecycle services, Aoop has completed around 2,500 digital transformation projects and has over 300 professionals certified on ServiceNow solutions. This expertise has led the company to become a ServiceNow Elite Partner in record time. The continuous commitment to excellence and the delivery of innovative solutions have established Aoop as a market reference, integrating intelligent efficiency throughout the entire production chain.
“Aoop leads the ServiceNow market in Brazil. Our integration with NTT DATA Business Solutions will allow us to further expand our solution offerings to existing customers, access new opportunities for joint solutions with SAP customers and accelerate our international expansion,” says Luiz Cesar Baptistella, CEO and founder of Aoop.
The acquisition of Aoop will add 120 customers to the portfolio of NTT DATA Business Solutions, which has been operating in Brazil for 25 years. Aoop will become a subsidiary of NTT DATA Business Solutions – Servicos de Tecnologia Ltda. in Brazil and will operate as an independent company after the acquisition, using the brand name “Aoop, an NTT DATA Company”.
For more information visit nttdata-solutions.com.
About NTT DATA Business Solutions
NTT DATA Business Solutions is a leading global IT service provider focused on SAP with a powerful ecosystem of partners. With more than 35 years of in-depth experience, we enable companies worldwide to become Intelligent Enterprises. We deliver end-to-end solutions that accelerate sustainable growth and success – from strategic consulting and implementation to managed services and beyond. As a global strategic SAP partner, we drive innovation and leverage the latest technologies to support our customers individually and across all industries. Our more than 15,300 dedicated employees in over 30 countries work passionately every day to make it happen.
NTT DATA Business Solutions is part of NTT DATA, a $30+ billion trusted global innovator of business and technology services headquartered in Tokyo. As One NTT DATA we serve 75% of the Fortune Global 100 and are committed to helping customers innovate, optimize and transform for long-term success. NTT DATA is part of NTT Group.
Press Contact NTT DATA Business Solutions
Local
Global
Sofia Baldessar
Sales Operation Director
NTT DATA Business Solutions –
Servicos de Tecnologia Ltda.
1440 Visconde de Nacar Street –
13th floor Curitiba, Paraná, Brazil
T: +55 41 988658826
Email: [email protected]
Jasmin Straeter
Head of Global Communications
NTT DATA Business Solutions AG
Königsbreede 1, 33605 Bielefeld, Germany
T: +49 521 9 14 48 108
Email: [email protected]

View original content:https://www.prnewswire.co.uk/news-releases/ntt-data-signs-agreement-to-acquire-aoop-and-will-become-a-leader-in-servicenow-solutions-in-latin-america-302274027.html

Continue Reading

Artificial Intelligence

Dun & Bradstreet Global Business Optimism Insights Report Shows Quarterly Increase

Published

on

dun-&-bradstreet-global-business-optimism-insights-report-shows-quarterly-increase

Improving market dynamics have provided relief, indicating confidence in both domestic and global economic conditions 
LONDON, Oct. 11, 2024 /PRNewswire/ — Dun & Bradstreet (NYSE:DNB), a leading global provider of business decisioning data and analytics, today released its Q4 2024 Global Business Optimism Insights report. The report, fielded in Q3 2024, found a 7% increase in business optimism quarter-over-quarter, driven by gradual easing of inflation rates and favorable borrowing conditions.

Nearly four in five businesses are expressing increased optimism in domestic and export orders, capital expenditures and financial risk due to a combination of easing financial pressures, shifts in monetary policies, robust regulatory frameworks and higher participation in sustainability initiatives.
U.S. businesses recorded a nearly 9% rise in optimism, aided by falling inflation and expectations of further rate cuts. Similarly, business optimism in the U.K. and Spain showed notable recoveries as their respective central banks initiated monetary easing, rising by 13% and 9%, respectively. Emerging economies, such as Argentina and India, saw jumps in optimism levels due to declining inflation and increased domestic demand respectively.
“While overall global business optimism has increased and inflation has abated, it’s important to recognise that geopolitics contribute to economic uncertainty,” said Neeraj Sahai, President of Dun & Bradstreet International. “Industry-specific regulatory risks and more stringent data requirements have emerged as the top concerns among a third of respondents. To mitigate these risks, businesses are considering diversifying their supply chains and markets to manage regulatory risk.”    
Key findings from the Q4 report’s five indices include:
The Global Business Optimism Index increased by 7.3% over Q3 2024. This is a significant increase with 75% of businesses, especially smaller businesses, expressing confidence in sales and domestic and export orders ahead of the holiday season. The real estate (12.5%) and utilities (10.4%) sectors saw the highest jumps in optimism levels.The Global Supply Chain Continuity Index improved 6.8%, stemming from businesses reducing burdens on their supply chains by adopting nearshoring, using alternative and less-congestive routes, and relying on domestic supplies. One in four businesses in the U.S., as well as Switzerland and Spain, are considering diversifying supply chains and markets as their preferred strategy to manage their regulatory risk.The Global Business Financial Confidence Index increased 6.3% due to expectations of improved financial conditions and reduced borrowing costs as many economies have started to cut interest rates. Confidence in the U.S. and South Korea notably improved by 5.2% and 11.2%, respectively, on indications of their central banks pivoting towards looser monetary policies.The Global Business Investment Confidence Index improved 3.6%, showcasing optimism in capital spending centered around signs of global monetary policies becoming more accommodative, along with improvement in macroeconomic activities.The Global Business ESG Index increased by 6.1%, stemming from businesses’ efforts to meet regulatory requirements, stricter disclosure mandates and heightened investor awareness. Globally, stricter environmental regulations, such as the European Union’s Carbon Border Adjustment Mechanism and the German Supply Chain Due Diligence Act, are among top concerns for 29% of businesses, resulting in almost one in four conducting risk assessments or implementing regulatory compliance strategies.Descriptions and information about the indices can be found on page 24 of the report.
“Businesses are increasingly confident as borrowing costs decline, boosting optimism for higher sales, stronger exports, and reduced financial risks,” said Arun Singh, Global Chief Economist at Dun & Bradstreet. “This confidence is driving capital investments, with easing supply chain pressures supporting growth in the year’s final quarter.”
About the Global Business Optimism Insights Report
The Global Business Optimism Insights report is a synthesis of data from a comprehensive survey encompassing 32 economies, covering approximately 10,000 businesses and 17 sectors, alongside insights from Dun & Bradstreet, leveraging the firm’s proprietary data and economic expertise. The report is an amalgamation of five indices which reflect overall business optimism and expectations about supply chain continuity, financial and investment conditions and ESG initiatives. An index reading above 100 indicates an improvement in optimism relative to the base year (Q3 2023 to Q2 2024), while an index reading below 100 signifies a deterioration in optimism.
View the full report here.
About Dun & Bradstreet
Dun & Bradstreet, a leading global provider of business decisioning data and analytics, enables companies around the world to improve their business performance. Dun & Bradstreet’s Data Cloud fuels solutions and delivers insights that empower customers to accelerate revenue, lower cost, mitigate risk, and transform their businesses. Since 1841, companies of every size have relied on Dun & Bradstreet to help them manage risk and reveal opportunity. For more information on Dun & Bradstreet, please visit www.dnb.com.

View original content:https://www.prnewswire.co.uk/news-releases/dun–bradstreet-global-business-optimism-insights-report-shows-quarterly-increase-302273151.html

Continue Reading

Artificial Intelligence

CRISIL jumps 12 places to 37th in Chartis RiskTech100 2025

Published

on

crisil-jumps-12-places-to-37th-in-chartis-risktech100-2025

Recognised as Category Leader in model validation for the third year in a row
MUMBAI, India, Oct. 11, 2024 /PRNewswire/ — CRISIL Ltd, the global provider of advanced analytics and credit risk management solutions, has risen 12 places to #37 in the RiskTech100 2025 report published by the London-based Chartis Research this month.

This is the second consecutive year that CRISIL has featured among the top 50. The independent annual assessment ranks the world’s 100 best providers of risk and compliance technology and services.
The report also recognises CRISIL as a Category Leader in model validation for the third consecutive year, based on a risk technology survey, product demonstration, customer reference checks, and third-party sources of information. The process evaluated CRISIL’s capabilities across the model risk lifecycle, including model development, validation, governance, inventory management, and risk management and control.
Gurpreet Chhatwal, Chief Operating Officer, CRISIL Limited, says, “These awards reflect the strength of our service and technology offerings in the risk management space. As traditional and emerging risks continue to multiply at an accelerating rate, our offerings are more crucial than ever before, and we continue to evolve them to adapt to a rapidly changing world.”
CRISIL’s risk management solutions expedite regulatory and internal compliance, enable informed decision-making, and deliver substantial cost efficiencies for financial institutions (Fis). Among the key solutions are:
Model Infinity: A cloud-ready platform for model inventory, workflow and governance. Leverages advanced analytics and robust reporting to address distinct model inventory and model risk management requirementsScenario Expansion Manager: An adaptable tool that empowers FIs to seamlessly define, design, expand and analyse regulatory and internal stress-testing scenarios with precision and flexibilityCredit+ Intelligent Credit Origination: Streamlines credit risk assessment and credit rating framework through a combination of objective and subjective methodologies, enabling decision-making at lendersCredit+ Early Warning Signals: A credit risk monitoring infrastructure for active surveillance of the credit portfolio. Combines internal and external data and a multi-dimensional trigger library to identify early warning signals at the facility/ instrument, borrower and portfolio levels to deliver granular insights and risk intelligenceCredit+ Loan Origination system: Enables seamless management and automation of the loan origination process by managing borrower and proposal data and adhering to workflows specified in the FI’s credit sanctioning policyInternal credit risk models: CRISIL’s 32 credit risk models help FIs rate a wide range of credits, including corporate (large, mid and small), sector-specific, project finance and retail exposuresAshish Vora, Head, CRISIL Market Intelligence and Analytics, says, “This recognition highlights the strength, depth and global reach of our award-winning credit and risk solutions, Credit+ Intelligent Credit Origination and Credit+ Early Warning Signals. We continue to invest in our products, leveraging generative artificial intelligence (GenAI)-driven analytics, cutting-edge technology and advanced credit risk capabilities, to provide world-class solutions to our clients.”
Last month, CRISIL was also recognised as a Category Leader in the RiskTech Regulatory Reporting Solutions Quadrant Report 2024.
Chartis Research is part of Infopro Digital, which encompasses multiple brands, digital channels and events across the finance, technology and corporate sectors. Their combined reach of more than 400,000 risk and compliance professionals makes the RiskTech100® report the most comprehensive study of its kind.
About CRISIL Limited
CRISIL Privacy policy
Connect with us: LINKEDIN | TWITTER | YOUTUBE | FACEBOOK 
Disclaimer
This press release is transmitted to you for the sole purpose of dissemination through your newspaper/ magazine/ agency. The press release may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution of its press releases for consideration or otherwise through any media including websites, portals, etc.
CRISIL has taken due care and caution in preparing this press release. Information has been obtained by CRISIL from sources which it considers reliable. However, CRISIL does not guarantee the accuracy, adequacy or completeness of information on which this press release is based and is not responsible for any errors or omissions or for the results obtained from the use of this press release. CRISIL, especially states that it has no financial liability whatsoever to the subscribers/ users/ transmitters/ distributors of this press release.
Logo: https://mma.prnewswire.com/media/2211784/4375397/CRISIL_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/crisil-jumps-12-places-to-37th-in-chartis-risktech100-2025-302273856.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending